AnaptysBio, Inc. (ANAB) Total Assets by Year
AnaptysBio, Inc. closed fiscal year 2025 with $364.4M in total assets, $327.2M in total liabilities and $37.2M in shareholder equity. This represents a decrease of 24.7% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters AnaptysBio, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ANAB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-KT | FY2410-KT | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $364.4M-24.7% | $483.8M+7.0% | $452.4M-25.9% | $610.4M-5.1% | $643.1M+54.4% | $416.6M-4.3% | $435.2M-14.5% | $509.0M+54.5% | $329.4M+429.7% | $62.2M | N/A |
| Total Liabilities | $327.2M-20.8% | $413.0M+13.4% | $364.3M+4.6% | $348.3M+21.5% | $286.6M+1346.2% | $19.8M-34.3% | $30.2M+33.4% | $22.6M+3.9% | $21.8M-78.3% | $100.4M | N/A |
| Total Equity | $37.2M-47.5% | $70.9M-19.6% | $88.1M-66.4% | $262.1M-26.5% | $356.4M-10.2% | $396.7M-2.0% | $405.0M-16.7% | $486.4M+58.1% | $307.6M+904.2% | -$38.2M-8.7% | -$35.2M |
ANAB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-KT | Q1'2610-Q | Q4'2510-KT | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-KT | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $317.0M-5.4% | $329.7M-21.9% | $364.4M-24.7% | $353.1M-28.4% | $335.3M-21.6% | $422.1M+4.0% | $483.8M+7.0% | $493.4M+1.3% | $427.4M-17.4% | $405.8M-26.5% | $452.4M-25.9% | $487.3M-21.2% |
| Total Liabilities | $306.4M-19.4% | $316.9M-18.3% | $327.2M-20.8% | $382.5M-6.5% | $380.0M-9.0% | $388.0M+8.4% | $413.0M+13.4% | $409.1M+11.5% | $417.5M+13.3% | $358.1M-0.7% | $364.3M+4.6% | $366.9M+7.6% |
| Total Equity | $10.6M+123.7% | $12.7M-62.5% | $37.2M-47.5% | -$29.4M-134.9% | -$44.7M-552.8% | $34.0M-28.8% | $70.9M-19.6% | $84.4M-29.9% | $9.9M-93.3% | $47.8M-75.0% | $88.1M-66.4% | $120.4M-56.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More AnaptysBio, Inc. financials
Frequently Asked Questions
What was AnaptysBio, Inc.'s total assets in fiscal year 2025?
AnaptysBio, Inc. closed fiscal year 2025 with $364.4M in total assets, $327.2M in total liabilities and $37.2M in shareholder equity.
How fast is AnaptysBio, Inc.'s total assets growing?
AnaptysBio, Inc. (ANAB) total assets fell by 24.7% year over year, from $483.8M to $364.4M in fiscal year 2025.
What was AnaptysBio, Inc.'s total assets in the most recent quarter?
AnaptysBio, Inc. (ANAB) reported $317.0M in total assets in Q2 2026. This represents a decrease of 5.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what AnaptysBio, Inc. (ANAB) reported on that line in every period on record.